USD 0.01
(-35.9%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2010 | 2009 |
---|---|---|---|---|---|---|
Operating Cash Flow | -2.43 | -19.03 Thousand | -33.73 | - | -455.06 Thousand | 825.46 Thousand |
Net Income | -6.43 | -92.37 Thousand | -33.73 | - | -3.12 Million | -2 Million |
Depreciation & Amortization | - | - | - | - | 3.48 Million | 3.69 Million |
Deferred income taxes | - | - | - | - | -1.06 Million | -460.4 Thousand |
Stock-based compensation | - | 61.67 | - | - | 501.31 Thousand | 607.24 Thousand |
Change in working capital | 4.00 | 11.67 Thousand | - | - | -345.18 Thousand | -1.61 Million |
Other non-cash items | - | 61.67 Thousand | - | - | 3.57 Million | 4.3 Million |
Investing Cash Flow | - | - | - | - | -694.06 Thousand | -10.05 Million |
Investments in PPE | - | - | - | - | -2.02 Million | -8.7 Million |
Acquisitions | - | - | - | - | 572.64 Thousand | - |
Investment purchases | - | - | - | - | -184.63 Thousand | -598.45 Thousand |
Sales/Maturities of investments | - | - | - | - | 350.69 Thousand | - |
Other Investing Activities | - | - | - | - | 1.16 Million | -745.44 Thousand |
Financing Cash Flow | -2.52 | 24 Thousand | 33.72 | - | 1 Million | 9.05 Million |
Debt repayment | -2.52 | -24 Thousand | - | - | -200 Thousand | -1.34 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | 33.72 | - | 1.2 Million | 10.4 Million |
Accounts receivables | - | - | - | - | -329.49 Thousand | 514.76 Thousand |
Accounts payables | - | - | - | - | 256.2 Thousand | -81.44 Thousand |
Inventory | - | - | - | - | -123.37 Thousand | -2766.00 |
Other working capital | 4.00 | 11.67 Thousand | - | - | -478.01 Thousand | -1.53 Million |
Cash at beginning of period | 4.95 | -12.00 | - | 277.3 Thousand | 426.43 Thousand | 592.66 Thousand |
Cash at end of period | - | 4952.00 | -0.01 | 277.3 Thousand | 277.3 Thousand | 426.43 Thousand |
Capital Expenditure | - | - | - | - | -2.02 Million | -8.7 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -4.95 | 4964.00 | -0.01 | - | -149.12 Thousand | -166.23 Thousand |
Free Cash Flow | -2.43 | -19.03 Thousand | -33.73 | - | -2.47 Million | -7.88 Million |
Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -1.80 | -6432.00 | -1.80 | -1.41 | -1.41 | -92.37 Thousand |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | 61.67 |
Change in working capital | 2.00 | 3998.00 | 2.00 | - | - | 11.67 Thousand |
Other non-cash items | - | - | - | - | - | 61.67 Thousand |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | -1.49 | -2519.00 | -1.49 | 0.23 | 0.23 | 24 Thousand |
Debt repayment | -2969.00 | -2519.00 | - | -450.00 | - | -24 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -1.49 | - | -1.49 | 0.23 | 0.23 | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 2.00 | 3998.00 | 2.00 | - | - | 11.67 Thousand |
Cash at beginning of period | 2575.00 | 4952.00 | - | 4952.00 | - | -12.00 |
Cash at end of period | -1.00 | -1.00 | -1.29 | 2575.00 | -1.19 | 4952.00 |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -2576.00 | -4953.00 | -1.29 | -2377.00 | -1.19 | 4964.00 |
Free Cash Flow | 0.20 | -2434.00 | 0.20 | -1.41 | -1.41 | -19.03 Thousand |
MDGEF
1808
NBNKF
PHAR
GURE
0086